Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bailey, 1994, The CCP4 suite-programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr., 50, 760, 10.1107/S0907444994003112
Bazzoni, 1998, Are changes in integrin affinity and conformation overemphasized?, Trends Biochem. Sci., 23, 30, 10.1016/S0968-0004(97)01141-9
Bazzoni, 1998, Divalent cations and ligands induce conformational changes that are highly divergent among β1 integrins, J. Biol. Chem., 273, 6670, 10.1074/jbc.273.12.6670
Bednar, 1997, Flow cytometric measurement of kinetic and equilibrium binding parameters of arginine-glycine-aspartic acid ligands in binding to glycoprotein IIb/IIIa on platelets, Cytometry, 28, 58, 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO;2-D
Beglova, 2002, Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation, Nat. Struct. Biol., 9, 282, 10.1038/nsb779
Billheimer, 2002, Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated, Blood, 99, 1, 10.1182/blood.V99.10.3540
Brooks, 1994, Integrin αVβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell, 79, 1157, 10.1016/0092-8674(94)90007-8
Conte, 1999, The atomic structure of protein-protein recognition sites, J. Mol. Biol., 285, 2177, 10.1006/jmbi.1998.2439
Dechantsreiter, 1999, N-Methylated cyclic RGD peptides as highly active and selective αVβ3 integrin antagonists, J. Med. Chem., 42, 3033, 10.1021/jm970832g
Du, 1991, Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa), Cell, 65, 409, 10.1016/0092-8674(91)90458-B
Du, 1993, Long range propagation of conformational changes in integrin αIIbβ3, J. Biol. Chem., 268, 23087, 10.1016/S0021-9258(19)49429-5
Egbertson, 1999, Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation, J. Med. Chem., 42, 2409, 10.1021/jm980722p
Falke, 2001, Transmembrane signaling in bacterial chemoreceptors, Trends Biochem. Sci., 26, 257, 10.1016/S0968-0004(00)01770-9
Frelinger, 1990, Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers, J. Biol. Chem., 265, 6346, 10.1016/S0021-9258(19)39332-9
Giblin, 2001, Antagonists of β2 integrin-mediated cell adhesion, Annu. Rep. Med. Chem., 36, 181, 10.1016/S0065-7743(01)36058-X
Hemler, 1998, Integrin associated proteins, Curr. Opin. Cell Biol., 10, 578, 10.1016/S0955-0674(98)80032-X
Huber, 1995, Determination of kinetic constants for the interaction between the platelet glycoprotein IIb-IIIa and fibrinogen by means of surface plasmon resonance, Eur. J. Biochem., 227, 647, 10.1111/j.1432-1033.1995.tb20184.x
Hughes, 1998, Integrin affinity modulation, Trends Cell Biol., 8, 359, 10.1016/S0962-8924(98)01339-7
Kouns, 1992, Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor, Blood, 80, 2539, 10.1182/blood.V80.10.2539.2539
Legler, 2001, Superactivation of integrin αVβ3 by low antagonist concentrations, J. Cell Sci., 114, 1545, 10.1242/jcs.114.8.1545
Liu, 2000, Integrin cytoplasmic domain-binding proteins, J. Cell Sci., 113, 3563, 10.1242/jcs.113.20.3563
Lu, 2001, Epitope mapping of antibodies to the C-terminal region of the integrin β2 subunit reveals regions that become exposed upon receptor activation, J. Immunol., 166, 5629, 10.4049/jimmunol.166.9.5629
Lu, 2001, Association of the membrane-proximal regions of the α and β subunit cytoplasmic domains constrains an integrin in the inactive state, J. Biol. Chem., 276, 14642, 10.1074/jbc.M100600200
Marvin, 2001, Manipulation of ligand binding affinity by exploitation of conformational coupling, Nat. Struct. Biol., 8, 795, 10.1038/nsb0901-795
Nermut, 1988, Electron microscopy and structural model of human fibronectin receptor, EMBO J., 7, 4093, 10.1002/j.1460-2075.1988.tb03303.x
Pampori, 1999, Mechanisms and consequences of affinity modulation of integrin αVβ3 detected with a novel patch-engineered monovalent ligand, J. Biol. Chem., 274, 21609, 10.1074/jbc.274.31.21609
Parise, 1987, Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa, J. Biol. Chem., 262, 12597, 10.1016/S0021-9258(18)45247-7
Perutz, 1989, Mechanisms of cooperativity and allosteric regulation in proteins, Q. Rev. Biophys., 22, 139, 10.1017/S0033583500003826
Peter, 1998, Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (αIIbβ3) inhibitors, Blood, 92, 3240, 10.1182/blood.V92.9.3240
Remy, 1999, Erythropoietin receptor activation by a ligand-induced conformation change, Science, 283, 990, 10.1126/science.283.5404.990
Scarborough, 2000, Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers, J. Med. Chem., 43, 3453, 10.1021/jm000022w
Shimaoka, 2002, Conformational regulation of integrin structure and function, Annu. Rev. Biophys. Biomol. Struct., 31, 485, 10.1146/annurev.biophys.31.101101.140922
Smith, 1994, A mechanism for divalent cation regulation of β3-integrins, J. Biol. Chem., 269, 960, 10.1016/S0021-9258(17)42205-8
Takagi, 2001, C-terminal opening mimics “inside-out” activation of integrin α5β1, Nat. Struct. Biol., 8, 412, 10.1038/87569
Tanford, 1961
Vinogradova, 2002, A structural mechanism of integrin αIIbβ3 “inside-out” activation as regulated by its cytoplasmic face, Cell, 110, 587, 10.1016/S0092-8674(02)00906-6
Xiong, 2001, Crystal structure of the extracellular segment of integrin αVβ3, Science, 294, 339, 10.1126/science.1064535
Xiong, 2002, Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand, Science, 295, 151, 10.1126/science.1069040
Yan, 2001, Mechanism of integrin activation by disulfide bond reduction, Biochemistry, 40, 8861, 10.1021/bi002902i